APOBEC3B and neoplasm: Indeed, depending on the level, duration, and model system, the expression of APOBEC3B can lead to various outcomes, including that of there being no overt tumor phenotypes [55,108], increased tumor rates [54], detriments to tumor development [43], or lethality [109].